These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
806 related items for PubMed ID: 24512768
1. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation. Xu PX, Wang SW, Yu XL, Su YJ, Wang T, Zhou WW, Zhang H, Wang YJ, Liu RT. Behav Brain Res; 2014 May 01; 264():173-80. PubMed ID: 24512768 [Abstract] [Full Text] [Related]
3. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Wang SW, Wang YJ, Su YJ, Zhou WW, Yang SG, Zhang R, Zhao M, Li YN, Zhang ZP, Zhan DW, Liu RT. Neurotoxicology; 2012 Jun 01; 33(3):482-90. PubMed ID: 22445961 [Abstract] [Full Text] [Related]
9. Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer's disease. Wang SW, Yang SG, Liu W, Zhang YX, Xu PX, Wang T, Ling TJ, Liu RT. Behav Brain Res; 2016 Jan 01; 296():109-117. PubMed ID: 26358659 [Abstract] [Full Text] [Related]
10. Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress. Yu XL, Li YN, Zhang H, Su YJ, Zhou WW, Zhang ZP, Wang SW, Xu PX, Wang YJ, Liu RT. Food Funct; 2015 Oct 01; 6(10):3296-306. PubMed ID: 26242245 [Abstract] [Full Text] [Related]
11. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction. Zhang W, Bai M, Xi Y, Hao J, Liu L, Mao N, Su C, Miao J, Li Z. Free Radic Biol Med; 2012 Apr 15; 52(8):1443-52. PubMed ID: 22342520 [Abstract] [Full Text] [Related]
12. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS. J Ethnopharmacol; 2011 Sep 01; 137(1):783-9. PubMed ID: 21762767 [Abstract] [Full Text] [Related]
13. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Izco M, Martínez P, Corrales A, Fandos N, García S, Insua D, Montañes M, Pérez-Grijalba V, Rueda N, Vidal V, Martínez-Cué C, Pesini P, Sarasa M. Neuroscience; 2014 Mar 28; 263():269-79. PubMed ID: 24447596 [Abstract] [Full Text] [Related]
19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A, Xu X, Bi X, Baudry M. J Alzheimers Dis; 2012 Mar 28; 30(1):183-208. PubMed ID: 22406441 [Abstract] [Full Text] [Related]
20. Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response. Ma Y, Li Y, Zong LX, Xing XN, Zhang WG, Cao YP. Brain Res; 2011 Jul 11; 1400():112-24. PubMed ID: 21658683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]